Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24523N0807
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,196
Award facts
- Contract value 100% obligated
- $12,195.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a delivery order award valued at approximately $12.2K from the Department of Veterans Affairs' Veterans Integrated Service Network 5 for JYNARQUE (tolvaptan) 90mg/30mg tablets. The contract, awarded on August 5, 2023, with an ultimate completion date of August 11, 2023, operates under a firm-fixed-price model with no set-aside designation. This delivery order was issued under the company's larger Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), which includes an $83.3M blanket purchase agreement specifically for JYNARQUE that runs through March 26, 2026. The medication will be delivered to Pittsburgh, Pennsylvania, where VISN 5 facilities will distribute it to veterans requiring treatment for autosomal dominant polycystic kidney disease and hyponatremia.
As a major pharmaceutical supplier to the VA's Veterans Health Administration, Otsuka America maintains significant indefinite delivery vehicles totaling approximately $396M across multiple VA integrated service networks. The company's consistent delivery of specialized pharmaceuticals through the GSA schedule demonstrates its established capability to support the VA's healthcare mission. This particular delivery order represents routine procurement activity under the existing blanket purchase agreement, enabling efficient fulfillment of pharmaceutical needs across the VA's veteran patient population.
Quick answers
Who was awarded contract 36C24523N0807?
36C24523N0807 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 5, 2023.
How much is contract 36C24523N0807 worth?
The government has obligated $12,196 on 36C24523N0807.
Is contract 36C24523N0807 an order under another contract?
Yes. 36C24523N0807 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24523N0807 competed?
The extent of competition for 36C24523N0807 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award